Epperly Melissa B, Insider Trading Activity

Average Profitability
21.94%
Insider Buys Quantity
3
Insider Buys Sum
$1.22M
Insider Sells Quantity
18
Insider Sells Sum
$3.32M

Insider Activity of Epperly Melissa B,

According to the SEC Form 4 filings, Epperly Melissa B,, being in a position of

  1. director at Roivant Sciences Ltd.,
    оver the last 12 months, has bought 0 shares, and sold 82299 shares for $2.65M,
    over all time since 2026-03-16, has bought 0 shares, and sold 82299 shares for $2.65M.

Biography of Epperly Melissa B,

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,647,9164100

Comparison of Insiders on Amount of Buys and Sells

2026-10-01SaleRoivant Sciences Ltd.
ROIV
director
17,750
0.0025%
$36.10$640,861+0.62%
2026-09-15SaleRoivant Sciences Ltd.
ROIV
director
4,938
0.0007%
$39.74$196,230-8.73%
2026-06-29SaleRoivant Sciences Ltd.
ROIV
director
17,750
0.0024%
$34.38$610,252+3.02%
2026-03-16SaleRoivant Sciences Ltd.
ROIV
director
41,861
0.0059%
$28.68$1.2M+20.47%
2024-02-12SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
2,573
0.0036%
$11.44$29,435-66.87%
2024-02-02SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
8,669
0.0116%
$11.54$100,040-65.92%
2023-10-04SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
5,482
0.0076%
$19.50$106,926-41.16%
2023-02-14SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
5,227
0.0088%
$19.98$104,411-3.24%
2023-02-13SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
2,624
0.0044%
$20.42$53,594-4.84%
2022-04-04SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
353
0.0007%
$52.44$18,511-56.08%
2022-02-23SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
1,913
0.0044%
$49.10$93,921-49.3%
2021-08-19PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
8,285
0.0185%
$52.00$430,800-2.55%
2021-08-18PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
1,326
0.003%
$52.00$68,948-2.4%
2021-07-01SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0069%
$51.27$158,054+2.09%
2021-06-01SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0076%
$54.05$166,641+0.28%
2021-05-03SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0075%
$59.24$182,635-6.79%
2021-04-05SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
17,107
0.0417%
$43.39$742,323+29.58%
2021-03-01SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0076%
$41.67$128,482+36.07%
2021-02-01SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0075%
$37.56$115,805+48.32%
2021-01-04SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Financial Officer
3,083
0.0075%
$51.91$160,034+3.81%
Total: 25
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.